Increased survival of patients with end-stage hepatocellular carcinoma due to intake of ONCOXIN®, a dietary supplement

Indian Journal of Cancer
M Al-MahtabS Rahman

Abstract

Treatment and management of patients with end-stage hepatocellular carcinoma (HCC) represents a formidable challenge to contemporary branches of medical sciences. The study presented here was conducted to assess the utility of nutrient supplement, if any, for management of patients with end-stage HCC. A total of 19 patients with end-stage HCC (Barcelona Clinic Liver Cancer [BCLC] staging D) were provided with ONCOXIN® for 3 months. Another 10 patients with end-stage HCC (BCLC stage D) with similar clinical conditions received conservative management, but they did not give consent for taking ONCOXIN® (non-ONCOXIN® group). All patients of both groups were followed on regular basis until their death. The results were expressed as mean and standard deviation. Comparison between groups was performed using Student's t-test or the Mann-Whitney U test. For categorical data, Chi-square or Fisher exact test was applied. All patients of the control group (non-ONCOXIN® group) (10 of 10 patients) died within 2 months after study commencement. On the other hand, 10 of 19 patients receiving ONCOXIN® died within 2 months (less than 53% patients) after the start of taking ONCOXIN® (P < 0.05, compared with patients of non-ONCOXIN® group). Five m...Continue Reading

References

Jan 30, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Giuseppe CabibboCalogero Cammà
Mar 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordi BruixUNKNOWN American Association for the Study of Liver Diseases
Sep 29, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sean F AltekruseDavid E Kleiner
Mar 3, 2012·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Daisuke MoriharaShotaro Sakisaka
Apr 12, 2012·World Journal of Gastroenterology : WJG·Hiroki NishikawaToru Kimura
Oct 13, 2012·World Journal of Hepatology·Giuseppe CabibboVito Di Marco

❮ Previous
Next ❯

Citations

Aug 7, 2017·Oncology Letters·Elena Díaz-RodríguezAtanasio Pandiella
Apr 2, 2019·Molecular and Clinical Oncology·Alexandr ShumskyFedor Petrovskiy
Aug 31, 2019·Oxidative Medicine and Cellular Longevity·Esther Hernández-SanMiguelPilar Sánchez-Gómez
Apr 17, 2018·International Journal of Oncology·Elena Díaz-RodríguezAtanasio Pandiella
May 17, 2019·Nutrients·Javier Pérez-PeñaAtanasio Pandiella
Jul 13, 2021·International Journal of Clinical Practice·Herney Andrés García-PerdomoLeonardo Oliveira Reis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.